The RNK PPA/BT-RB Stethoscope is intended for use in detecting and amplifying heart, lung and other body sounds for diagnostic or monitoring purposes on a patient.

Device Description

The RNK PPA/BT-RB Stethoscope is comprised of a PCP Chest Piece assembly, an Amplifier Module containing an amplifier which amplifies the signal from the PCP Chest Piece and a Bluetooth wireless transmitter, and a standard audio Headset, plus an optional Bluetooth Headset.

The PCP Chest Piece assembly includes an attached cable terminated in a standard 3.5 mm audio stereo plug, which plugs into the Chest Piece port of the Amplifier Module. A standard, off-theshelf Headset with a 3.5 mm stereo audio plug can plug into the Headset port of the Amplifier Module to enable a listener to hear the amplified sounds from the PCP Chest Piece. Optionally, an off-the-shelf Bluetooth Headset can be used to listen to the signal from the PCP Chest Piece over a Bluetooth connection to the Bluetooth transmitter in the Amplifier Module.

The RNK Amplifier is powered by x2 AAA NiMH batteries, which can be recharged from a wall mount 5vdc power supply with a micro-USB connector. The Ampifier Module is not functional as a stethoscope while the batteries are being charged.

The RNK PPA/BT-RB Stethoscope provides up to about 20 times greater amplitude signal than a typical acoustic stethoscope. The overall auscultation frequency response of the RNK PPA/BT-RB Stethoscope is 20 Hz - 1,500 Hz.

AI/ML Overview

Here's an analysis of the provided text regarding the RNK PPA/BT-RB Stethoscope, focusing on acceptance criteria and supporting studies.

It's important to note that the provided documents (510(k) summary and FDA letter) are a regulatory submission and approval, not a detailed scientific study report. Therefore, much of the requested information about specific study designs (sample sizes, expert qualifications, ground truth establishment, MRMC studies) is not present in the given text. The information below is extracted and inferred only from what is provided.

Acceptance Criteria and Reported Device Performance

The acceptance criteria are not explicitly listed in a table with numerical targets in the provided document. Instead, the document relies on demonstrating "substantial equivalence" to a predicate device (RNK Electronic Stethoscope, K072026). The "acceptance criteria" are thus implicitly met by demonstrating similar performance and safety characteristics to the predicate device.

Acceptance Criteria (Implied by Predicate Equivalence)	Reported Device Performance (RNK PPA/BT-RB Stethoscope)
Intended Use: Detection and amplification of heart, lung, and other body sounds for diagnostic/monitoring.	Intended for use in detecting and amplifying heart, lung and other body sounds for diagnostic or monitoring purposes on a patient. (Matches predicate)
Technological Characteristics: Similar principles of operation.	Uses the same amplifier circuit and enclosure as the predicate device (RNK Electronic Stethoscope).
Amplitude Signal: Capable of sufficient amplification.	Provides up to about 20 times greater amplitude signal than a typical acoustic stethoscope.
Frequency Response: Appropriate range for auscultation.	Overall auscultation frequency response of 20 Hz - 1,500 Hz.
Electrical Safety: Conformance to relevant standards.	Successfully demonstrated conformance to IEC60601-1:2005 3rd Edition Medical Electrical Equipment Part 1: General Requirement for Safety.
EMC Immunity: Conformance to relevant standards.	Successfully demonstrated conformance to EN60601-1-2, 2007/03, EMC Immunity Requirements for Medical Electrical Equipment Part 1: General Requirements for Safety, 2. Collateral Standard - Electromagnetic Compatibility Requirements and Tests.
Biocompatibility: Safe for patient/clinician contact.	Uses the same materials that a patient or clinician might touch; Biocompatibility Analysis is the same as the predicate.
Auscultation Performance: Clinically equivalent performance.	Passed the same auscultation performance tests as the predicate device both in bench testing and by clinicians.

Study Details (Based on Provided Text)

Sample sizes used for the test set and the data provenance:
- Test Set Sample Size: Not specified. The document states "passed the same auscultation performance tests as the predicate device both in bench testing and by clinicians," implying some level of clinical evaluation, but details like the number of patients or sounds are not provided.
- Data Provenance: Not specified. Given the regulatory submission context for a US market, it's generally assumed internal testing, but no country of origin for specific data is mentioned. The document doesn't indicate if it was retrospective or prospective.
Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Number of Experts: Not specified. The document mentions "by clinicians" but does not quantify them or detail their roles in establishing ground truth.
- Qualifications of Experts: Not specified.
Adjudication method (e.g., 2+1, 3+1, none) for the test set:
- Not specified. The methodology for how clinicians "passed" the performance tests is not detailed.
If a multi-reader multi-case (MRMC) comparative effectiveness study was done:
- No, an MRMC comparative effectiveness study was not explicitly mentioned or detailed. The submission emphasizes "substantial equivalence" to a predicate device, which usually involves demonstrating similar performance rather than a direct comparison of human reader effectiveness with and without the new device. The phrase "passed the same auscultation performance tests as the predicate device both in bench testing and by clinicians" suggests direct comparison of the device's output/performance to the predicate, rather than human reader improvement with the device.
- Effect size of human readers improve with AI vs without AI assistance: Not applicable, as this device is an electronic stethoscope (an amplification and transmission tool) and not an AI-powered diagnostic system.
If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- Yes, in part. The document states the device "passed the same auscultation performance tests as the predicate device both in bench testing and by clinicians." "Bench testing" would fall under standalone performance for the device's technical specifications (e.g., amplitude, frequency response, electrical safety, EMC). The "clinicians" part suggests a human-in-the-loop component, but the pure technical measurement (e.g., of frequency response) is standalone.
The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- Not explicitly defined. For auscultation performance, the "ground truth" for "passing" tests would likely be based on established audiological standards for stethoscopes and potentially subjective clinical assessment by the "clinicians" mentioned, comparing the sounds heard and their diagnostic utility to those from the predicate device. It is not mentioned to be pathology or outcomes data.
The sample size for the training set:
- Not applicable. This device is an electronic stethoscope that amplifies and transmits sound; it does not involve machine learning or AI that would require a "training set."
How the ground truth for the training set was established:
- Not applicable, as there is no training set for this type of device.

Summary

{0}------------------------------------------------

RNK Products, Inc.

K132405 P 1/2

OCT 1 1 2013

510(k) SUMMARY RNK Products, Inc. PPA/BT-RB Stethoscope

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

The assigned 510(k) number is: K132405

Submitter Information

Submitter:

RNK Products, Inc. 8247 Devereux Drive, Suite 101 Viera, FL 32940 Telephone: (321) 610-3980 Facsimile: (321) 610-3979

Contact Person: Date Prepared:

Charles R. Abbruscato October 9, 2013

Device Information

Name of Device	RNK PPA/BT-RB Stethoscope
Common or Usual Name	Electronic Stethoscope
Classification Name	Electronic Stethoscope
Predicate Devices	RNK Electronic Stethoscope (K072026)

Device Description

{1}------------------------------------------------

Intended Use

The RNK PPA/BT-RB Stethoscope is intended for use in detecting and amplifying heart, lung and other body sounds for diagnostic or monitoring purposes on a patient.

Substantial Equivalence

The RNK PPA/BT-RB Stethoscope is substantially equivalent to the RNK Electronic Stethoscope (K072026). Both use the PCP Chest Piece and the PPA/BT-RB Amplifier Module uses the same amplifier circuit and the same enclosure as the predicate device.

Both the PPA/BT-RB Stethoscope and the predicate device successfully demonstrated conformance to IEC60601-1:2005 3rd Edition Medical Electrical Equipment Part 1: General Requirement for Safety and to EN60601-1-2, 2007/03, EMC Immunity Requirements for Medical Electrical Equipment Part 1: General Requirements for Safety, 2. Collateral Standard -Electromagnetic Compatibility Requirements and Tests. Since both devices use the same materials that a patient or clinician might touch, the Biocompatibility Analysis is the same. The PPA/BT-RB Stethoscope passed the same auscultation performance tests as the predicate device both in bench testing and by clinicians.

The RNK PPA/BT-RB Stethoscope has the same intended use, principles of operation and technological characteristics as the auscultation function of the predicate device. There are no new questions of safety or effectiveness.

{2}------------------------------------------------

Public Health Service

Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is a stylized symbol of three abstract human figures connected at the arms, forming a triangular shape.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002

October 11, 2013

RNK Products, Inc. c/o Mr. Charles Abbruscato C.E.O. 8247 Devereux Dr., Suite 101 Melbourne, FL 32940 US

Re: K132405

Trade/Device Name: PPA/BT-RB Stethoscope Regulation Number: 21 CFR 870.1875 Regulation Name: Electronic Stethoscope Regulatory Class: Class II Product Code: DQD Dated: August 29, 2013 Received: August 30, 2013

Dear Mr. Charles Abbruscato:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Page 2 - Mr. Charles Abbruscato

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also. please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Image /page/3/Picture/4 description: The image shows the text "Sincerely yours." at the top. Below the text is a signature that is difficult to read due to its illegibility. The signature appears to be written in black ink. The background of the image is plain and white.

for Bram D. Zuckerman, Ph.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

K132405

Indications for Use

510(k) Number (if known): _K132405

Device Name: __ RNK PPA/BT-RB Stethoscope

Indications for Use:

The RNK PPA/BT-RB Stethoscope is intended for use in detecting and amplifying heart, lung and other body sounds for diagnostic or monitoring purposes on a patient.

(Please Do Not Write Below This Line - Continue On Another Page If Needed)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Image /page/4/Picture/8 description: The image shows a logo with the letters "FDA" prominently displayed. The letters are stylized and overlapping, with a circular design behind them. The logo appears to be a stylized representation of the Food and Drug Administration.

Prescription Use: X (Per CRF 801.109)

Over-the-Counter Use _________________________________________________________________________________________________________________________________________________________

(Optional Format 1-2-96)

Regulation Number and Section

§ 870.1875 Stethoscope.

(a)
Manual stethoscope —(1)Identification. A manual stethoscope is a mechanical device used to project the sounds associated with the heart, arteries, and veins and other internal organs.(2)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.(b)
Electronic stethoscope —(1)Identification. An electronic stethoscope is an electrically amplified device used to project the sounds associated with the heart, arteries, and veins and other internal organs.(2)
Classification. Class II (special controls). The device, when it is a lung sound monitor, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.